FUJIFILM Diosynth Biotechnologies vs Takeda: CDMO Comparison
How does FUJIFILM Diosynth Biotechnologies compare to Takeda for AAV manufacturing?
Side-by-side comparison of FUJIFILM Diosynth Biotechnologies and Takeda on independent FDA inspections, EMA and MHRA GMP certificates, clinical-program activity, and CDMO Signal Score. Data sourced from FDA, EMA EudraGMDP, MHRA GMDP, and ClinicalTrials.gov.
Key differences
- Takeda has more FDA inspections on record (4 vs 0) — a deeper regulatory paper trail.
- Both maintain clean enforcement records — no FDA OAI classifications or warning letters on file for either CDMO.
- FUJIFILM Diosynth Biotechnologies maintains 6 MHRA / UK GMP certificates; Takeda does not.
- Takeda appears as a manufacturing partner on more matched clinical programs (100 vs 0) — a broader sponsor book.
On a 13-modality CDMO landscape, both FUJIFILM Diosynth Biotechnologies and Takeda qualify as AAV manufacturers; FUJIFILM Diosynth Biotechnologies carries the higher composite Signal Score for AAV programs in this comparison.
What to evaluate for AAV programs
Both FUJIFILM Diosynth Biotechnologies and Takeda qualify as AAV CDMOs. When choosing between them for AAV programs, weigh these four dimensions specifically — each carries through to the side-by-side scorecard above.
Platform & scale
Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record.
Capsid quality
Full/empty capsid ratio and aggregate control drive potency and safety. Ask about AUC, anion-exchange separation, and the analytics package for capsid characterization.
Regulatory readiness
For programs heading to BLA, a strong FDA inspection history and EMA/MHRA GMP coverage matter — both are shown above and on each profile.
Capacity & timelines
AAV manufacturing slots can be constrained. Weigh the capacity signal and clinical-program load before committing.
Frequently asked: FUJIFILM Diosynth Biotechnologies vs Takeda
How does FUJIFILM Diosynth Biotechnologies compare to Takeda for AAV manufacturing?
On CDMO Signal's composite Signal Score, FUJIFILM Diosynth Biotechnologies is 85/100 and Takeda is 82/100; FUJIFILM Diosynth Biotechnologies has 0 FDA inspections on record vs 4 for Takeda; European coverage is 23 active EMA+MHRA certificates for FUJIFILM Diosynth Biotechnologies vs 18 for Takeda. Both are tracked in the CDMO Signal directory as AAV CDMOs. The scorecard above breaks down every metric side by side — use it alongside each CDMO's individual profile for the full regulatory and clinical footprint.
Which has the stronger FDA inspection record, FUJIFILM Diosynth Biotechnologies or Takeda?
Both FUJIFILM Diosynth Biotechnologies and Takeda maintain clean enforcement records on file — no FDA warning letters and no OAI classifications. FUJIFILM Diosynth Biotechnologies has 0 FDA inspections on record; Takeda has 4.
How do FUJIFILM Diosynth Biotechnologies and Takeda compare on European GMP coverage?
FUJIFILM Diosynth Biotechnologies holds 17 active EMA GMP certificates and 6 MHRA / UK certificates. Takeda holds 18 active EMA GMP certificates and 0 MHRA / UK certificates. Use these counts as a proxy for the breadth of each CDMO's European regulatory footprint.
Which is more active in clinical-stage manufacturing — FUJIFILM Diosynth Biotechnologies or Takeda?
FUJIFILM Diosynth Biotechnologies is matched to 0 ClinicalTrials.gov records as a manufacturing partner; Takeda is matched to 100. Higher counts indicate broader sponsor exposure but say nothing about approved-product track record — pair this number with each CDMO's profile page for context.
Which is better for AAV manufacturing — FUJIFILM Diosynth Biotechnologies or Takeda?
Both FUJIFILM Diosynth Biotechnologies and Takeda are tagged as AAV CDMOs in our directory, so both are credible options for AAV programs. The most important differentiator for AAV selection is typically platform & scale: Suspension processes scale better than adherent (HEK293) for commercial volumes. Confirm the CDMO's largest validated bioreactor scale and serotype track record. Review each CDMO's profile and inspection record before shortlisting.
Use the free AI matchmaker to weigh both against your specific requirements — capacity, modality, regulatory record, geography — and surface other qualified options.
Find & compare CDMOs →